CytomX Therapeutics (CTMX)
(Delayed Data from NSDQ)
$1.60 USD
-0.03 (-1.84%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $1.60 0.00 (0.00%) 6:32 PM ET
3-Hold of 5 3
C Value C Growth F Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/14/24 |
---|---|
Current Quarter | -0.04 |
EPS Last Quarter | 0.01 |
Last EPS Surprise | -50.00% |
ABR | 2.71 |
Earnings ESP
|
-12.50% |
---|---|
Current Year | -0.29 |
Next Year | -0.38 |
EPS (TTM) | -0.02 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 21.92M | 22.02M | 87.02M | 82.28M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 27.00M | 27.00M | 108.00M | 108.00M |
Low Estimate | 12.50M | 12.50M | 50.00M | 50.00M |
Year ago Sales | 23.50M | 24.72M | 101.21M | 87.02M |
Year over Year Growth Est. | -6.72% | -10.91% | -14.03% | -5.44% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.04 | -0.05 | -0.29 | -0.38 |
# of Estimates | 5 | 5 | 5 | 5 |
Most Recent Consensus | 0.02 | 0.01 | 0.04 | -0.17 |
High Estimate | 0.02 | 0.01 | 0.04 | -0.12 |
Low Estimate | -0.11 | -0.15 | -0.75 | -0.70 |
Year ago EPS | -0.05 | -0.02 | -0.01 | -0.29 |
Year over Year Growth Est. | 20.00% | -150.00% | -2,800.00% | -30.34% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 1 | 1 | 0 | 1 |
Down Last 7 Days | 0 | 0 | 1 | 1 |
Down Last 30 Days | 0 | 0 | 1 | 1 |
Down Last 60 Days | 2 | 2 | 4 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.04 | -0.05 | -0.29 | -0.38 |
7 Days Ago | -0.02 | -0.03 | -0.21 | -0.29 |
30 Days Ago | -0.02 | -0.03 | -0.21 | -0.29 |
60 Days Ago | -0.08 | -0.08 | -0.11 | -0.29 |
90 Days Ago | -0.08 | -0.08 | -0.06 | -0.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.05 | -0.07 | -0.36 | -0.44 |
Zacks Consensus Estimate | -0.04 | -0.05 | -0.29 | -0.38 |
Earnings ESP | -12.50% | -34.62% | -22.41% | -15.08% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.01 | 0.04 | -0.02 | -0.05 | NA |
Estimate | 0.02 | -0.17 | -0.19 | -0.16 | NA |
Difference | -0.01 | 0.21 | 0.17 | 0.11 | 0.12 |
Surprise | -50.00% | 123.53% | 89.47% | 68.75% | 57.94% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more